KZR

Kezar Life Sciences, Inc. is a clinical-stage biotechnology company based in South San Francisco, California, focused on developing innovative small molecule therapies to tackle unmet medical needs in immune-mediated diseases and cancer. Leveraging its proprietary drug discovery platform, Kezar aims to pioneer treatments that offer new hope to patients suffering from these challenging conditions. With a robust pipeline of candidates undergoing clinical evaluation, the company is positioned to make significant strides in the biotechnology sector, targeting high-impact therapeutic areas that promise to enhance patient outcomes.